Group 1: Medical Ultrasonics

  • The development of real-time 3D ultrasound imaging is constrained by two fundamental challenges: probe design and acquisition speed.
  • Medical ultrasound (US) imaging technology is experiencing a new Renaissance, marked by the continuous emergence of innovative methods and instruments.
  • Short-lag spatial coherence beamforming was initially introduced as a clutter reduction technique for cardiac ultrasound imaging.
  • Ultrasound Localization Microscopy (ULM) enables microvascular imaging far beyond the diffraction limit, but most implementations remain confined to 2D.
  • Immunotherapy has revolutionized cancer treatment, but significant limitations remain across solid tumor indications.
  • Transcranial ultrasound brain imaging has a broad range of potential applications, including intracerebral hemorrhage detection, brain perfusion assessment, cerebrovascular disease diagnosis, and functional imaging of neural activity.
  • This talk will present recent evidence demonstrating that Transcranial Ultrasound Stimulation (TUS) can induce transient, targeted neuroplastic changes in the human brain, with implications for both mechanistic research and therapeutic development.

Group 2: Sensors, NDE and Industrial Application

  • Modern industrial and biomedical challenges increasingly demand multimodal sensing solutions that integrate acoustic, optical, and electromagnetic approaches.
  • We introduce an enzyme-free, wearable microneedle patch (ARMPatch) for continuous glucose monitoring (CGM) using standard ultrasound.

Group 3: Physical Acoustics

  • Phononic (acoustic-wave) integrated circuits offer unique advantages for sensing and analog computing beyond conventional electronic and optical platforms.

Group 4: Microacoustics / Acoustic Resonators and Filters

  • The filter market was a relatively ‘backwater’ technology fueling radar and other like rf devices. Even with the SAW filter in the early 1990s and FBAR in 2000, there was nothing to excite investors and get the attention of Wall Street.
  • Recent advances in scandium-doped aluminum nitride (ScAlN) have opened new opportunities for high-performance RF and mmWave acoustic devices through the exploitation of its enhanced piezoelectricity and ferroelectricity.
  • Two widely used approaches for defining the effective electromechanical coupling constant, k2t,eff2, in piezoelectric bulk acoustic wave (BAW) resonators are the IEEE and overlap-integral definitions. Both formulations originate from the fundamental energy-ratio definition of coupling.

Group 5: Transducers and Transducer Materials

  • The application of ultrasound technology to medical therapeutics, which has been in development for decades, is now seeing a massive increase both in pre-clinical and clinical uptake across a wide variety of applications.
  • Textured piezoelectric ceramics offer the potential to combine the ultrahigh piezoelectricity of single crystals with the mechanical robustness, property uniformity and cost advantages of conventional ceramics.
  • Biomedical ultrasound is widely used for medical imaging and intervention, but ultrasound alone is insufficient for precision diagnosis and therapy.
  • The presentation discusses the use of transcranial low-intensity ultrasound for noninvasive, deep-brain neuromodulation.

Clinical Speakers

  • Neuromuscular ultrasound (NMUS) is increasingly seen as an essential in providing care for diseases of nerve and muscle.

  • The talk will then explore emerging applications of blood-brain barrier opening, including liquid biopsy, biomarker discovery, and targeted delivery of therapeutics to the central nervous system. Beyond ablation and drug delivery, the presentation will highlight the rapidly advancing field of FUS neuromodulation.

  • This talk will provide a comprehensive overview of the current shift from structural grayscale to advanced functional neurosonography in the clinic, while mapping out the critical translational breakthroughs, technical limitations, and collaborative industry partnerships needed to shape the future of neonatal neuroimaging.